EDIGENE INC.

Company Snapshot

Founded: 2015
Entity Type: Private
Region: China
Headquarter: Beijing, China
Key Geographics: China
Corporate Address: Building 2, No. 22, Science Park Road, Zhongguancun Life Science Park, Changping District, Beijing China Tel. +86-10-8073-3899 www.edigene.com

Company Overview

Founded in 2015, EdiGene Inc. is developing therapeutics and drug discovery products using its genome-editing platforms.

EdiGene has operational subsidiaries in Guangzhou, China, and Cambridge, Mass. EdiGene has developed several gene-editing platforms; the main focus is on moving these platforms to therapeutics for rare diseases and for drug discovery applications.

EDIGENE INC. In Reports

Synthetic Biology: Global Markets

BCC Research Market Report for synthetic biology is estimated to increase from $9.5 billion in 2021 to $33.2 billion by 2026, at a compound annual growth rate of 28.4%

Synthetic Biology: Global Markets

The global synthetic biology market should grow from $5.3 billion in 2019 to $18.9 billion by 2024 with a compound annual growth rate (CAGR) of 28.8% for the period of 2019-2024.

Synthetic Biology: Global Markets

The global synthetic biology market should grow from $5.3 billion in 2019 to $18.9 billion by 2024 with a compound annual growth rate (CAGR) of 28.8% for the period of 2019-2024.

Company's Business Segments

  • Genome Editing : This segment bringing Transformative Therapies to patients in various disease areas such as Tumors, Neuromuscular Diseases, Autoimmune System Diseases.

Applications/End User Industries

  • Genome Editing
  • Gene Therapy
  • Cell Therapy
  • Genetic Diseases
  • Cancer
  • Biotechnology
  • Life Sciences
AI Sentiment